Finance

Lists
ATXI:OTCMKTS
Avenue Therapeutics Inc
USD 0,38
0,00%
(0,00) 1D
5 Okt., 09:30:02 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ATXI...
Mkt. cap
1,34 m
Avg. vol.
10,42 k
Volume
60,00
52-wk high
USD 0,97
52-wk low
USD 0,15
EPS
-USD 0,86
Beta
0,42
Shares outstanding
3,30 m
No. of employees
1
Mkt. cap
1,34 m
Avg. vol.
10,42 k
Volume
60,00
52-wk high
USD 0,97
52-wk low
USD 0,15
EPS
-USD 0,86
Beta
0,42
Shares outstanding
3,30 m
No. of employees
1
News stories
From web sources and news partners
About Avenue Therapeutics Inc
CEO-
Employees1
Founded2015
HeadquartersBay Harbor Islands, Florida, Verenigde State van Amerika
SectorPharmaceutical industry
Websiteavenuetx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
177,00 k
257,00 k
200,00 k
247,00 k
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
547,00 k
698,00 k
514,00 k
460,00 k
Operating expense
724,00 k
955,00 k
714,00 k
707,00 k
Total operating expenses
724,00 k
955,00 k
714,00 k
707,00 k
Operating income
-724,00 k
-955,00 k
-714,00 k
-707,00 k
Other non operating income
-2,00 k
1,00 k
1,00 k
-
EBT including unusual items
-692,00 k
-726,00 k
-695,00 k
-690,00 k
EBT excluding unusual items
-692,00 k
-929,00 k
-695,00 k
-690,00 k
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-683,00 k
-709,00 k
-695,00 k
-690,00 k
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
34,00 k
25,00 k
18,00 k
17,00 k
Interest expense
-
-
-
-
Net interest expenses
34,00 k
25,00 k
18,00 k
17,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme